Prophylactic administration of recombinant human thrombopoietin attenuates XELOX or SOX regimen-induced thrombocytopaenia.
作者信息
Li Quanfu, Jin Gaowa, Jiang Caihong, Zhang Zewei, Hou Jixiang, Zhao Juan, Chen Feng, Li Zhenhao
机构信息
Department of Medical Oncology, Ordos Central Hospital, China.
Department of Radiation Oncology, Sun Yat-sen University Cancer Centre; State Key Laboratory of Oncology in South China; Collaborative Innovation Centre for Cancer Medicine, China.
出版信息
Arch Med Sci. 2021 Aug 9;17(5):1440-1446. doi: 10.5114/aoms/141134. eCollection 2021.
Abstract
摘要
Zotero 插件